title: Expanding the paradigm of eosinophilic esophagitis: mast cells and IL-9.
authors.forename: Yui-Hsi
authors.initials: YH
authors.lastname: Wang
authors.forename: Simon P
authors.initials: SP
authors.lastname: Hogan
authors.forename: Patricia C
authors.initials: PC
authors.lastname: Fulkerson
authors.forename: J Pablo
authors.initials: JP
authors.lastname: Abonia
authors.forename: Marc E
authors.initials: ME
authors.lastname: Rothenberg
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D057765:Eosinophilic Esophagitis / Q000188:drug therapy*; D006801:Humans; D015848:Interleukin-5 / Q000037:antagonists & inhibitors*; D016906:Interleukin-9 / Q000378:metabolism*; D008407:Mast Cells / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D015848:Interleukin-5; D016906:Interleukin-9; C434107:mepolizumab